<DOC>
	<DOCNO>NCT00666029</DOCNO>
	<brief_summary>To characterize feature metabolic syndrome volunteer . To undertake randomised trial determine whether treatment statin improve muscle microvascular blood flow .</brief_summary>
	<brief_title>Implications Treatment Metabolic Syndrome</brief_title>
	<detailed_description>To characterise feature metabolic syndrome , include body fat , insulin sensitivity , liver fat together muscle micorvascular blood flow . To undertake randomised control trial atorvastatin 40 mg. o.d 6 month determine whether measure change treatment .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Body mass index ( BMI ) 2035 kg/m^2 '' `` &gt; 3 criterion metabolic syndrome , one hypertriglyceridaemia , i.e . fast plasma triglyceride &gt; 2.0 mmol/L cardinal lipid abnormality syndrome NCEP III ATP metabolic syndrome criterion : Waist great equal 102 cm BP great 130 / 85 TG great equal 1.7mmol/l Glucose great equal 6.1 mmol/l HDL le 1.0 mmol/l Aged &lt; 18 year &gt; 75 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>metabolic syndrome</keyword>
	<keyword>Volunteers recruit community</keyword>
</DOC>